So the practical takeaway is not oral is better or SC is better. It is: pick one route, follow the documented per-dose figure for the vial you have, and keep the route constant so that whatever you observe is not confounded by a mid-stream route change
The trial tested oral administration primarily, and no controlled study has tested subcutaneous injection in humans
Heightened inflammation: Dysregulated NF-kB pathways promote pro-inflammatory cytokines
The mechanism makes sense
The right choice depends entirely on your primary goal, whether its appetite control, direct fat mobilization, or systemic metabolic optimization
AOD-9604 isolates the fat metabolism benefits of HGH without systemic growth hormone effects, making it appropriate for individuals seeking metabolic support without the broader hormonal changes or side effect profile of HGH therapy